CaniVax Limited (“CaniVax”, “we”, “us”) is a company based in Oxford, United Kingdom, developing investigational cancer vaccines for canine use. These investigational cancer vaccines are not currently authorised by the Veterinary Medicines Directorate and are not approved for general veterinary use. CaniVax seeks to operate in compliance with applicable UK laws, regulations, and professional standards relating to veterinary medicines, research, communications, and data protection. Nothing on the Website should be interpreted as indicating that any investigational cancer vaccine or investigational approach is authorised, clinically proven, safe, or effective for general veterinary use.
The content of this website (the “Website”) is provided for general informational and educational purposes only. The Website should not be relied upon as a basis for veterinary, medical, financial, or investment decisions. Nothing on the Website constitutes veterinary advice, diagnosis, or treatment, and the content must not be relied upon as a substitute for consultation with a qualified veterinary surgeon. Decisions regarding the health, care, or treatment of any animal should always be made in consultation with an appropriately qualified veterinary professional. Use of the Website, or any communication through it, does not create any veterinary-client, veterinarian-patient, advisory, fiduciary, or other professional relationship between CaniVax and any user.
Investigational cancer vaccines remain subject to ongoing research, development, and regulatory review. Safety, efficacy, and clinical utility have not been established, and no representation or warranty is given regarding the safety, efficacy, suitability, availability, or clinical benefit of any investigational approach described on the Website. No claim is made that any investigational approach provides a cure, and clinical outcomes cannot be guaranteed. Individual responses may vary.
Access to investigational cancer vaccines may occur only through regulated clinical studies or other appropriately authorised veterinary pathways, where applicable and in accordance with relevant laws and regulations. Participation in any clinical study or investigational programme is subject to eligibility criteria, regulatory approvals, veterinary assessment, and other applicable requirements, and cannot be guaranteed. Participation in clinical studies or access to investigational approaches may involve costs, which may vary depending on the study protocol, veterinary provider, and individual case. CaniVax does not provide financial, insurance, reimbursement, or funding advice. Users are responsible for understanding any associated costs and should discuss these with their veterinary provider.
The Website may contain information regarding CaniVax’s research activities, development programmes, scientific concepts, and business strategy. Such information is provided for general background purposes only and does not constitute, and should not be construed as, an offer to sell, a solicitation of an offer to buy, or a recommendation regarding any securities, investments, or financial instruments. Any forward-looking statements involve known and unknown risks, uncertainties, and assumptions which may cause actual outcomes or developments to differ materially from those expressed or implied.
While CaniVax makes reasonable efforts to ensure that information on the Website is accurate and up to date, no representation or warranty, express or implied, is made regarding the accuracy, completeness, reliability, suitability, or currency of any content. The Website may contain links to third-party websites or external resources. CaniVax does not control and accepts no responsibility for the content, accuracy, availability, or security of third-party materials, and inclusion of any link does not imply endorsement or association.
To the fullest extent permitted by law, CaniVax excludes all liability for any loss, damage, cost, or expense arising from or in connection with the use of, or reliance upon, the Website or its content. Nothing in this disclaimer excludes or limits liability for death or personal injury caused by negligence, fraud, fraudulent misrepresentation, or any other liability which cannot lawfully be excluded or limited under applicable law.
The Website is intended primarily for users located in the United Kingdom. Regulatory requirements, legal restrictions, and the availability of investigational approaches may differ in other jurisdictions.
All intellectual property rights in the Website and its content are owned by or licensed to CaniVax unless otherwise stated. No material from the Website may be copied, reproduced, distributed, modified, republished, transmitted, or otherwise used without prior written permission from CaniVax.
CaniVax reserves the right to modify, suspend, update, or remove any part of the Website or its content at any time without notice. Any personal data submitted through the Website will be handled in accordance with our Privacy Policy.
This disclaimer and any dispute or claim arising out of or in connection with it or the Website shall be governed by and construed in accordance with the laws of England and Wales. The courts of England and Wales shall have exclusive jurisdiction.